Holding(s) in Company
May 18 2006 - 12:05PM
UK Regulatory
RNS Number:2329D
Cambridge Antibody Tech Group PLC
18 May 2006
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. Name of shareholder having a major interest
CREDIT SUISSE
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
CREDIT SUISSE SECURITIES (EUROPE) LIMITED NOT KNOWN
CREDIT SUISSE INTERNATIONAL NOT KNOWN
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
CREDIT SUISSE SECURITIES (EUROPE) LIMITED 2,464,567
CREDIT SUISSE INTERNATIONAL 9
5. Number of shares / amount of stock acquired
NOT DISCLOSED
6. Percentage of issued class
N/A
7. Number of shares / amount of stock disposed
N/A
8. Percentage of issued class
N/A
9. Class of security
ORDINARY 10 PENCE SHARES
10. Date of transaction
16 MAY 2006
11. Date company informed
18 MAY 2006
12. Total holding following this notification
2,464,576
13. Total percentage holding of issued class following this notification
4.63%
14. Any additional information
THOSE CREDIT SUISSE COMPANIES WHICH ARE DIRECT OR INDIRECT HOLDING COMPANIES OF
CREDIT SUISSE SECURITIES (EUROPE) LIMITED AND CREDIT SUISSE INTERNATIONAL ARE,
UNDER THE TERMS OF SECTION 203 OF THE ACT, EACH INTERESTED BY ATTRIBUTION IN ANY
SHARES IN WHICH CREDIT SUISSE SECURITIES (EUROPE) LIMITED AND CREDIT SUISSE
INTERNATIONAL ARE INTERESTED.
15. Name of contact and telephone number for queries
JUSTIN HOSKINS 01223 898589
16. Name and signature of authorised company official responsible for making
this notification
JUSTIN HOSKINS, COMPANY SECRETARY
Date of notification
18 MAY 2006
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAXSPFELKEFE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2023 to Sep 2024